Atlanta—June 20, 2014—Liaison Technologies, a global provider of secure, cloud-based integration and data management services and solutions, entered into an agreement with Accenture, a global management consulting, technology services and outsourcing company to provide the big data technology platform needed to help develop evidence-driven business models to deliver the best possible patient results for target populations. Under this agreement, Accenture made a minority investment in Liaison Technologies. Terms of the investment were not disclosed.
“This relationship brings together the capabilities of both organizations to offer clients a more complete set of solutions for cloud integration and data management across many industries, such as consumer goods, retail, health and life sciences,” said Bob Renner, CEO of Liaison Technologies. “Companies today are seeking solutions that can be tailored to their individual needs, and our Cloud Integration Platform allows for infinite opportunities for companies to transform their businesses.”
With over $250 million invested in its Cloud Integration Platform to date, Liaison offered a solid cloud offering for over a decade. Cloud technology was a part of Liaison since its inception, making it natural to move into a role as a cloud services broker and become a player in the emerging big data space.
“Life sciences companies are faced with the growing complexity of data and what to effectively do with it,” said Jeff Elton, managing director of Accenture’s Life Sciences Precision Health Intelligence. “We look forward to collaborating with Liaison so we can—through Accenture’s Precision Health Intelligence solution—provide a strong data-driven approach to help life sciences companies yield better insights for determining which combination of services and treatments improve patient outcomes, as well as the quality and affordability of healthcare.”
